Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-11
DOI: 10.2147/dddt.s610324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Kailin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Chang…. Hauptthemen laut MEDLINE: Quinolines, Nasopharyngeal Carcinoma, Indoles, Nasopharyngeal Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, 410013, People's Republic of China.
- Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, People's Republic of China.
- Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, 410013, People's Republic of China.
Zitieren
APA
Chen, K., Li, Y., Chen, X., Zhu, W., Shi, Y., Ye, X., Jiang, C., Li, Y., & Liu, F. (2026). Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study. Drug Design, Development and Therapy, Volume 20, 1-11. https://doi.org/10.2147/dddt.s610324
Vancouver
Chen K, Li Y, Chen X, Zhu W, Shi Y, Ye X, et al. Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study. Drug Design, Development and Therapy. 2026;Volume 20:1-11. doi:10.2147/dddt.s610324
BibTeX
@article{Chen2026,
author = {Chen, Kailin and Li, Yuyi and Chen, Xiaoyu and Zhu, Weichang and Shi, Yuchen and Ye, Xu and Jiang, Cuihong and Li, Yajun and Liu, Feng},
title = {Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--11},
doi = {10.2147/dddt.s610324}
}
EUVIMED